Voyager Therapeutics Inc (VYGR)
5.655
+0.22
(+4.14%)
USD |
NASDAQ |
Nov 22, 16:00
5.65
0.00 (0.00%)
After-Hours: 20:00
Voyager Therapeutics Revenue (TTM): 163.78M for Sept. 30, 2024
Revenue (TTM) Chart
Historical Revenue (TTM) Data
Date | Value |
---|---|
September 30, 2024 | 163.78M |
June 30, 2024 | 143.77M |
March 31, 2024 | 119.04M |
December 31, 2023 | 250.01M |
September 30, 2023 | 158.40M |
June 30, 2023 | 194.87M |
March 31, 2023 | 190.73M |
December 31, 2022 | 40.91M |
September 30, 2022 | 70.53M |
June 30, 2022 | 30.92M |
March 31, 2022 | 31.57M |
December 31, 2021 | 37.41M |
September 30, 2021 | 15.88M |
June 30, 2021 | 132.24M |
March 31, 2021 | 159.56M |
December 31, 2020 | 171.13M |
September 30, 2020 | 197.26M |
June 30, 2020 | 99.86M |
Date | Value |
---|---|
March 31, 2020 | 117.26M |
December 31, 2019 | 104.39M |
September 30, 2019 | 73.72M |
June 30, 2019 | 55.39M |
March 31, 2019 | 11.87M |
December 31, 2018 | 7.619M |
September 30, 2018 | 11.96M |
June 30, 2018 | 11.01M |
March 31, 2018 | 9.612M |
December 31, 2017 | 10.13M |
September 30, 2017 | 6.151M |
June 30, 2017 | 8.311M |
March 31, 2017 | 10.85M |
December 31, 2016 | 14.22M |
September 30, 2016 | 16.80M |
June 30, 2016 | 18.42M |
March 31, 2016 | 19.59M |
December 31, 2015 | 17.33M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
15.88M
Minimum
Sep 2021
250.01M
Maximum
Dec 2023
121.48M
Average
125.64M
Median
Revenue (TTM) Benchmarks
Rhythm Pharmaceuticals Inc | 112.53M |
NovaBay Pharmaceuticals Inc | 13.84M |
Palatin Technologies Inc | -- |
iBio Inc | -- |
Theriva Biologics Inc | -- |